id: 334, Created by Stan Vick, Scout
How it works?
- Company agreed to settle with investors to avoid further litigation
- We prepare documents and claim payout for you
Claim deadline for this case already passed by, but we can still try and file for compensation for you
17 Jul 2017Class period Start
23 May 2018Class period End
08 Oct 2022Claim deadline
Recro Pharma agreed to pay $1.4 million to settle a securities class action lawsuit accusing the Company of deceiving investors about material information.
The original complaint alleged that the Company and its Leaders misled investors through a series of public statements regarding Recro’s target opportunities that allegedly inflated Recro’s stock price, in particular, they misrepresented and/or omitted Key Opinion Leader concerns about the drug IV meloxicam.
Recro Pharma agreed to settle with investors to avoid further litigation.
Pomerantz LLP, Kaskela Law LLC, Bronstein, Gewirtz & Grossman LLC
Hon. Michael M. Baylson
Strategic Claims Services
Court hearing date
26 October 2022
+$1,400,000Total Settlement Amount